RPRX - Royalty Pharma plc - Ordinary Shares - Class A
IEX Last Trade
29.03
-0.100 -0.344%
Share volume: 2,939,681
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$29.13
-0.10
-0.34%
Summary score
50%
Profitability
40%
Dept financing
44%
Liquidity
75%
Performance
55%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.85%
Return on assets
1.77%
Return on sales
58.02%
Return on invested capital
1.18%
Total debt ratio
65.47%
Debt ratio change over timeo
275.34%
Current Ratio
9.89%
Quick Ratio
10.07%
Cash Position Ratio
6.94%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.11%
Return on assets
1.39%
Return on sales
63.51%
Return on invested capital
1.4%
Total debt ratio
61.11%
Debt ratio change over timeo
497.04%
Current Ratio
9.11%
Quick Ratio
9.11%
Cash Position Ratio
4.82%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0.07%
Return on assets
-0.55%
Return on sales
87.27%
Return on invested capital
0.03%
Total debt ratio
59.71%
Debt ratio change over time
17.05%
Current Ratio
12.52%
Quick Ratio
12.52%
Cash Position Ratio
7%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
2091.29%
Return on assets
1104.72%
Return on sales
15342.13%
Return on invested capital
836.82%
Total debt ratio
27533.59%
Debt ratio change over time
275.34%
Current Ratio
4128.86%
Quick Ratio
4355.62%
Cash Position Ratio
2462.78%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RPRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 2.85% | 18.83% | 17.34% | 7.6% |
| Return on assets | 1.77% | 4.16% | 8.21% | 3.22% |
| Return on sales | 58.02% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 1.18% | 9.79% | -219.55% | 7.46% |
| Profitability | 37% | 75% | 66% | 50% |
| Total debt ratio | 65.47% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | 275.34% | -4.38% | -0.73% | -33.74% |
| Dept financing | 45% | 25% | 17% | 18% |
| Current Ratio | 9.11% | 1.12% | 0% | 1.16% |
| Quick Ratio | 9.11% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.82% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 6% | 6% | 8% |
| Short-term ratios | RPRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 3.11% | 13.31% | 0% | 13.48% |
| Return on assets | 1.39% | 4.72% | 0% | 3.05% |
| Return on sales | 63.51% | 31.4% | 0% | 25.56% |
| Return on invested capital | 1.4% | 10.68% | 0% | 13.96% |
| Profitability | 41% | 81% | 0% | 76% |
| Total debt ratio | 61.11% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 497.04% | -41.82% | 0% | 7.13% |
| Dept financing | 44% | 25% | 0% | 19% |
| Current Ratio | 9.11% | 1.12% | 0% | 1.16% |
| Quick Ratio | 9.11% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.82% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 6% | 0% | 8% |